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Clough, 1915, (1) employing a solution of alcohol precipitable  protein derived 
from pneumococci, tested patients suffering from pneumonia  by intradermal in- 
jections.  There resulted  in some instances  a  slightly  elevated  discrete  papule 
surrounded  by an indefinite zone of hyperemia;  all of the reactions  faded in 24 
hours.  Little or no difference was noted between the reactivity of patients with 
pneumonia and normal individuals,  nor was the reaction  affected by the stage of 
the disease in which the test was made.  Well, 1916, (2) prepared material  from 
cultures  of Type I pneumococcus.  He allowed the organisms to autolyze at 37°C. 
for 2 hours, followed by heating at 60°C. for 1 hour.  0.1 cc. to 0.2 cc. of the super- 
natant fluid of this solution was used for skin tests.  He obtained no reaction  in 
patients  tested during the acute phase  of the disease.  However,  1 to 21 days 
after crisis, injections  produced  a circumscribed erythema with slight infiltration 
at the point of puncture.  A few cases did not react at any time; normal persons 
and  patients  suffering  from  other  diseases gave  no  uniform  response.  In 
1917, Steinfeld  and  Kolmer  (3)  carried  out a  series of skin  tests,  employing 
heat  killed  Type  I,  II,  and  III pneumococci.  The  reactions  were  read  48 
hours after the injection;  when positive  the local lesion lasted 4 to 5 days.  Six 
of 19 pneumonia  patients gave positive reactions with one or another of the test 
organisms.  No relation  was noted between  the type of pneumococcus eliciting 
the skin response and the causative  organism of the disease.  All of the positive 
reactions were obtained in patients tested  after the crisis. _ Tests on control indi- 
viduals were recorded as being negative.  Weiss and Kolmer, 1918, (4) employed 
in a study of the cutaneous reaction of pneumonia patients, so-called pneumotoxin 
prepared  by dissolving washed pneumococci in 2 per cent sodium choleate.  This 
material was freshly made and standardized  in terms of minimal lethal  doses for 
guinea  pigs.  The reactions  were read 48 hours  after the injection.  In adults 
positive reactions'were  obtained in 100 per cent of 31 acute cases.  The period of 
reactivity ranged from the fifth day (2 days before crisis) to the thirteenth  day 
(6 days after crisis) of disease.  In children, tests were positive  during the acute 
phase of illness and negative  after recovery.  No correlation  was noted between a 
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positive test and the type of pneumococcus derived from the sputum.  Bigelow, 
1922, (5) prepared several varieties of test materials; they consisted of heat killed 
pneumococci,  autolysates, and solutions.  In  some  instances  the  material  was 
derived from pooled cultures of Types I, II,  III,  and Group IV pneumococci; 
other preparations were prepared from organisms  of a single type.  In tests on 
104 patients, he described two types of reaction.  One of these was designated as 
type specific.  It was described as an indurated papule surrounded by an areola, 
which reached its height 28 to 32 hours after inoculation.  This form of response 
was best obtained with autolysates.  It was considered by the author to be type 
specific since in 8 of 11 cases the material eliciting a positive reaction corresponded 
in type to that of the pneumococcus  recovered from the patient.  In 3 patients 
this correlation did not occur.  The second or "common" reaction was obtained 
with most of the preparations.  Lesions of this character reached their height in 
18 hours and faded in 24 to 36 hours.  It was obtained in 42.3 per cent of those 
tested and, in most instances,  was elicited after crisis had taken place.  Forty- 
five per cent of control individuals  also gave this reaction.  The author concludes 
that positive tests occur most commonly at the time during which antibodies would 
be present in greatest concentration.  Herrold and Traut,  1927, (6)  employed 
filtrates derived from a 5 day culture of an avirulent Type I  pneumococeus.  Re- 
actions, when positive, appeared in about 12 hours and reached the maximum after 
18 hours.  Readings  were made at the end of 24 hours.  Of 38 patients acutely 
ill with pneumonia, 73 per cent failed to react, while only 15 per cent of normal 
persons, gave negative tests.  Eight patients were repeatedly tested; one of these, 
negative at first, later became positive; another, originally positive, subsequently 
became negative; 2 were positive and 4 negative throughout the period of observa- 
tion.  They state that they found no relation between the material used for posi- 
tive tests and the type of pneumococcus causing the infection. 
From this review of the literature it will be seen that uniform results 
have not been obtained in pneumonia patients tested intracutaneously 
with pneumococcus products.  It will be further noted that, with the 
exception of  Clough  (1)  who  used  pneumococcus protein,  the  tests 
have been made with autolysates, heat killed organisms, solutions of 
pneumococci, and  culture filtrates.  Materials  of this  character are 
known  to  contain  a  variety of bacterial  products,  such  as protein, 
carbohydrate,  pneumotoxin,  hemolysin,  and  the  purpura  producing 
substance,  as well as other derivatives of enzyme action,  in varying 
concentrations.  Attention is directed to this point since the results 
reported in this paper demonstrate that  the composition of the mate- 
rial used for injection influences the character of the reaction. 
In  the experiments presented in  the present communication meas- 
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were  separately  employed  for  intradermal  injection  into  patients 
acutely ill with and convalescent from lobar pneumonia.  The mate- 
rial used for testing consisted of:  1.  The purified, protein-free, carbo- 
hydrates of Types I, II, and III pneumococci,--the so-called soluble 
specific substances; 2.  The somatic proteins of Pneumococcus.  This 
material,  the  acetic  acid  precipitable  fraction,  consists  largely  of 
nudeo-protein.  A  description of both carbohydrate  and protein is 
given  further on.  It  has been shown by  Avery  and  Heidelberger 
(7) that the pneumococcus carbohydrates are the type specific  com- 
ponents; they react only in homologous type specific anti-sere, and, in 
purified form, are not antigenic.  The protein fraction, on the other 
hand, is a common constituent of the pneumococcus species; antibodies 
elicited by immunization with it, react with protein derived from any 
strain of this organism. 
In addition to the intradermal injection of the polysaccharides and 
protein, the experiments were supplemented by obtaining serum from 
the patients just prior to the skin test, and titrating for the presence 
or absence of antibodies reactive with the test solutions. 
Material  and Methods 
Skin  Testing Materials.  1. Soluble Specific Subslances.--Type  specific  poly- 
s&ccharides from each of three pneumococcus Types (I, II, and IH) were em- 
ployed.  They were obtained in purified state according to the method employed 
in this laboratory by Heidelberger and Avery (8).  As demonstrated by Heidel- 
berger, Goebel, and Avery (9),  these substances possess the chemical properties 
of complex sugars; they contain no phosphorous, no sulfur, and give none of the 
usual protein color tests.  Type II and Type HI substances are nitrogen-free. 
The Type I  substance differs  from the other two in containing nitrogen as an 
apparently essential component.  The total nitrogen present in Type I  is 5 per 
cent, half of which is present in the 8vn|no form.  Despite the presence of nitrogen, 
the substance fails to give any of the protein color  reactions.  For skin tests, the 
polysaccharides were dissolved  in freshly prepared physiological  salt solution in 
such concentration that 0.t cc. of solution contained  0.0i mgm. of specific poly- 
saccharide.  For purposes of sterility the  solutions were heated at 100°C. for 10 
minutes before being used. 
2.  Pneumococcus Protein.--The material was prepared according to the method 
described  by Avery and Morgan (10).  Cultures of an R strain of pneumococcus 
originally derived from Type H  S organisms served as the source from which the 
protein was obtained.  The preparations  were  filtered through Berkefeld filters 
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ardized by nitrogen determinations and diluted in fresh physiological  salt solution 
so that 0.1 cc. of solution contained 0.01 mgm. of protein. 
In each instance the material was injected in 0.1 cc. amounts into the skin on 
the flexor surface of the forearm. 
Titration of Sera for Antibodies.--Blood,  obtained from patients by venapunc- 
ture, was allowed  to dot, centrifuged, and the clear serum pipetted off.  Tests 
for precipitins reactive with carbohydrate and protein were separately carried out. 
0.2 cc. serum diluted with 0.3 cc. physiological  salt solution was mixed with 0.5 
cc.  of varying dilutions of the precipitinogens.  Readings were made after the 
tubes had been allowed to incubate at 37°C. for 2 hours and then placed in the ice- 
box over night.  It was  found  that  type specific  antibodies  were more easily 
demonstrable by agglutination tests with the intact type specific cells.  Conse- 
quently this test was more commonly used.  0.5 cc. of varying dilutions of serum 
was mixed with 0.5 cc. of heat killed organisms of each of Types I, II and III. 
The tubes were incubated at 37°C.  for 2 hours and kept on ice over night.  A 
positive reaction was detected by the presence of the characteristic disc formation. 
On admission to the hospital patients were injected intradermally with Types 
I, II and III carbohydrate solutions,  protein solution,  and a control injection of 
fresh physiological  salt solution.  The tests were  often  repeated  several times 
both  during the acute phase of the illness  and  after  crisis.  Freshly prepared 
materials were always employed for injection.  This precaution was considered 
to be of considerable  importance since it was found that solutions which had been 
standing  for  several days often  gave rise  to  immediate  reactions  which  were 
deceptive.  In addition to skin tests, serum obtained, in most instances at  the 
time of intradermal injection, was titred for antibodies reactive with the carbohy- 
drates and protein.  Typing of the pneumococcus derived from the sputum of 
the tested patients was also carried out. 
Cutaneous Reactions to Specific Polysaccharides 
Observation on the  skin reaction of nineteen  individuals  suffering 
from  lobar  pneumonia  have  been  made  following  injection  of  0.01 
mgm. of each of the type specific polysaccharides.  Classified on the 
basis of the  pneumococcus  type derived from the  patient,  the  cases 
may be divided into:  11  cases of Type I  infection; 3 of Type II; 2 of 
Atypical Type II; and 3  of Group IV.  Unfortunately,  no instances 
of Type III pneumococcus infection were available during the period 
of this investigation.* 
* While this communication was in press a patient, convalescent from Type III 
pneumococcus pneumonia, has shown a positive reaction with the Type III poly- 
saccharide.  The patient's serum contained type-specific antibodies at the time 
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In the  11 cases of Type I  infection,  10 reacted to Type I  S carbo- 
hydrate and none to the Type II or III substances.  Of the 3 Type 
II cases one reacted to Type II polysaccharide, whereas all three were 
negative to the sugars derived from Types I  and III.  The 2 atypical 
Type II and the 3 Group IV cases were entirely negative. 
With regard to the time of appearance of a  positive reaction, none 
of the  cases before recovery reacted positively.  Of the  11  cases in 
which a positive test was obtained, 10 reacted at the time of recovery. 
One patient, suffering from Type I  pneumococcus pneumonia did not 
give a positive skin test until  the twenty-sixth day after recovery from 
the acute phase of the illness.  He had persistent fever, and  evidence 
of pleurisy during this time and only after these signs of persistent  in- 
fection began to subside did the skin test become positive. 
A  positive reaction, when obtained, was very striking  and may be 
described as follows: 
Ten to twenty minutes after the intradermal inoculation, there appears at the 
site of injection a wheal-like swelling with intense white edema.  Surrounding the 
wheal, a zone of erythema appears which becomes increasingly larger and more 
intense.  The edges are irregular due to the "pseudopods" of erythema extending 
in different directions.  The height  of the reaction occurs between 30 and 60 
minutes  after the inoculation.  (See  Figs. 1 and 2.)  Within  another  hour  the 
acute phase has entirely faded; a gradual regression then takes place leaving a 
firm, pale,  edematous area which may require 24 hours or longer to disappear 
completely.  Reactions  of this  character  have  been found to be strictly  type 
specific and to occur only with the polysaccharide corresponding to the serologi- 
cal type of the infecting organism.  At the site of injection of the carbohydrates 
of heterologous types and of the salt solution, no reaction appeared.  The "wheal 
and erythema" form of reaction, just described, differs strikingly from the delayed 
response elicited by the bacterial protein. 
In testing the sera of patients, it was found that in all instances in 
which a  positive skin reaction was elicited with the  specific carbohy- 
drates, agglutinins for the homologous type of pneumococcus and pre- 
cipitins for the reacting polysaccharide were present.  Furthermore, the 
time at which specific antibodies were demonstrable in the circulation 
has been coincident with the development of a positive skin reaction. 
However, the  fact  that  individuals  may possess circulating  specific 
antibodies  without  responding  to  the  intradermal  injection  of  the 
homologous specific substance will be subsequently shown. 
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gous specific polysaccharide was obtained, suffered from Type I pneu- 
mococcus infection.  Eight of these cases were treated with Type I 
antipneumococcus horse serum in 100 cc. doses at six hour intervals 
until recovery.  Regardless of the amount of serum administered the 
skin reaction did not become positive until the patient had clinically 
recovered.  The investigations are  not as yet sufficiently extensive 
to determine the exact relations between specific antibodies introduced 
therapeutically and the occurrence of a positive skin reaction.  How- 
ever, the results are suggestive that the production of a local response 
with  the  specific polysaccharide may,  under certain  conditions, be 
helpful  in  determining when  sufficient  serum  treatment  has  been 
given.  Studies are being continued in an attempt to determine this 
point. 
The single instance of Type I infection, which failed to react to the 
Type I carbohydrate occurred in a patient who developed pneumococ- 
cus meningitis and died on the twentieth day of disease.  This patient, 
after receiving 800  cc.  of serum,  possessed demonstrable circulating 
Type  I  antibodies,  but  gave  only  doubtful  or  negative  skin  test. 
Another individual, after recovering from the acute phase of the ill- 
ness, continued to run a low grade fever and showed signs of pleurisy. 
He  reacted  positively to  the  Type  I  specific  substance only after 
beginning cessation of infection.  These two  cases  suggest that per- 
sistence of infection, even though specific antibodies are present, may 
inhibit the skin response. 
In two patients suffering from Type I  pneumococcus pneumonia, 
no serum was administered.  In both instances a  positive skin re- 
sponse was obtained after recovery, indicating that a positive test is 
not  dependent upon  the presence of  therapeutic  serum.  Of  three 
Type II cases included in this series one gave a typical positive reac- 
tion to  the Type II specific polysaccharide..  The reaction first ap- 
peared as the result of a test made the day after, crisis; the patient's 
serum at this time contained Type II agglutinins and precipitins.  The 
other two Type II patients failed to react even to 0.1 mgm. of specific 
substance.  These failures occurred despite the fact that the blood 
serum, in each cage, contained specific Type II antibodies and that 
all evidence of infection had completely subsided.  As formerly noted 
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fection gave no response at any time to the skin tests with the poly- 
saccharides of Types I, II, or III. 
In all patients, tests were repeated every few days during convales- 
cence.  Those patients in whom the reactions were positive on several 
occasions and subsequently  became  negative,  ceased to react at the 
time  of disappearance  of  specific antibodies  from  the  circulation. 
In Table I a protocol of five cases is given, which serves to show the 
time  of  appearance  and  duration  of  skin  sensitivity  in  relation  to 
both  recovery  of  patient  and  occurrence  of  demonstrable  specific 
antibodies in the circulation. 
Cases Ka.  and  La.  suffered from Type I  pneumococcus infection and were 
treated with Type I antipneumococcus horse serum.  Case  Ka. is interesting in 
that skin sensitivity to Type I  carbohydrate and circulating Type I  antibodies 
have persisted for 127 days after recovery; observations on this patient  are being 
continued.  Case  La. first reacted on the day after recovery; three days later his 
capacity to react had ceased coincident with the disappearance of specific agglu- 
tinins and precipifius.  Patient Ca., the case of pneumococcus  meningitis referred 
to above failed to give a definite positive reaction at any time.  Cases  St. and Mo. 
were instances of spontaneous recovery from Type I and Type II pneumococcus 
infections, respectively.  They each gave typical responses after crisis and con- 
tinued to do so, as long as demonstrable circulating antibodies were present.  In 
the other patients, who gave a positive skin test, the same relations were found to 
hold as those presented in Table I. 
The local reaction resulting from the intradermal  injection of 0.01 
mgm. of the type specific polysaccharides presented three distinctive 
characteristics; first, the carbohydrate eliciting a response was always 
homologous in type to that of the  infecting  organism;  second,  both 
the  gross  appearance  of  the  lesion  and  the  rapidity  with  which  it 
developed and retrogressed were characteristic  of  the  typical  wheal 
and  erythema  type of  reaction;  third,  the  capacity to  react,  when 
evident, developed at the time of the patient's recovery, and was, in 
this group of cases, correlated with the presence of homologous type 
specific agglutinins and precipitins. 
Cutaneous Reactions  to Pneumococcus Protein 
The local reaction  resulting  from the intradermal  injection  of 0.1 
mgm. pneumococcus protein presented distinct differences from that CUTANEOUS  REACTIONS  IN  LOBAR  PNEUMONLA
Skin Reactions with Pneumococcus Polysaccharides  in Rdel,
Day of  disease ..................  1  2  3  4  5  6  7  8  9  10  11  12
Ka.  Agglutinins  - +++  ++
Age  14  Precipitins  - +  +
Type  I  Skin  Test.  neg.  pos.  pos.
C
La.  Agglutinins  - - -
Age 34  Precipitins  - +  -
Type I  Skin Test.  neg.  pos.  pos.  neg.
C
Ca.  Agglutinins  - ++  +++  ++t
Age 55  Precipitins  - +  +  +
Type I  Skin Test.  neg.  neg.  neg.  neg.  ?
St.  Agglutinins 
Age 33  Precipitins
Type I  Skin Test.  neg.  C  pos.
Mo.  Agglutinins  - |+++
Age 33  Precipitins  +  +
Type II  Skin Test.  neg.  pos.  pos.
C
Agglutinin  titre  in  terms  of  highest  positive  serum  dilution.  Agglutination
characterized  by disc formation.
- = Completely negative.
~-  = Doubtful  agglutination in serum dilution of 1:2.
+  =  Agglutination in serum dilution of 1:2.
+ +  =  Agglutination in serum dilution of  1:10.
+ + +  =  Agglutination in serum dilution of 1:20.
+ + + +  =  Agglutination in serum  dilution of 1:40.
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re of Circulating Specific Antibodies and Recovery of Patient
15  16  1718  19  20  21  22  23  242627  28  29  49  97  109  133
++  +  +  +  +  +
+  +  +  +  + -
pos.  pos.  pos.  pos.  pos.  pos.
neg.
+  +..
1os.  pos.
'++  .-.-.-.  (47)
+  +
)os.  pos.  neg.
Precipitin test  = 0.3  cc. serum +  0.2 cc. salt solution  +  0.5 cc.  1-40,000 dilu-
tion of polysaccharide.
Skin test:
pos.  =  positive  reaction.
i  =  doubtful reaction.
neg.  =  negative reaction.
C  =  day of crisis.
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obtained with the  carbohydrates.  Of  twelve patients tested  while 
acutely ill,  all failed to  react.  In eight individuals repeated injec- 
tions were made both before and after recovery.  Seven of them gave 
positive tests  after  crisis,  and also with each repetition of the test 
during convalescence.  These patients have not been retested since 
discharge from the hospital. 
A test, when positive, developed slowly as compared with the reac- 
tion elicited by the carbohydrates.  In 6 to  8 hours there appeared a 
small,  dark  red,  circumscribed lesion,  about  0.5  cm.  in  diameter. 
It gradually increased in size until a maximum was reached in 18 to 24 
hours.  Readings were recorded at this time.  (See Fig. 3.)  Regres- 
sion which began after 36 to 48 hours, usually proceded slowly, and 3 
to 4 days often were required for complete disappearance.  When at 
its height, the lesion varied from 1 to 5 cm. in diameter; it consisted 
of a small central papule, dark red in color, surrounded by a bright pink 
erythema; the edges faded gradually into normal skin; slight tender- 
ness was some times present and the local temperature often seemed to 
be increased.  The protein reactions were similar in many respects to 
the tuberculin response.  That this type of reaction, in contrast to 
the response induced by polysaccharides, was unrelated to the type of 
pneumococcus causing infection is borne out by the fact that of the 7 
patients, in whom positive tests were obtained, 2 had Type I  pneu- 
monia, 2 Type II, 2 Atypical Type II, and 1 Group IV. 
In determining the presence of pneumococcus protein precipitins, 
it was found that the  sera of all  the patients possessed antibodies 
reactive with this test material.  The titre ranged from 1:2,000  to 
1:16,000  in  the  different  cases.  However,  in  a  single  individual, 
variations in amount of precipitins occurring coincident with the prog- 
ress of  the disease  were  not  sufficiently striking nor constant to be 
considered of significance.  In Table  II,  the  results of the protein 
skin tests are given for those cases in which repeated injections were 
made. 
Table II" shows the relation of the development of skin sensitivity 
both to the time of recovery from infection and to the titre of anti- 
protein antibodies with serum.  From the data it appears that  the 
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reaction to the carbohydrate, is unrelated to the quantity of precipi- 
tins present in the circulation. 
The presence of antibodies to pneumococcus  protein in the serum of 
human beings, has not, as a search of the literature reveals, been the 
subject of previous investigation.  The possible significance of their 
occurrence is a part of this, as yet uncompleted, study.  In addition 
to the cases cited above, the sera of 13 other pneumonia patients have 
been tested at frequent intervals after admission to the hospital until 
discharge.  They were  all  found to  possess in  their  serum protein 
precipitins in concentrations comparable to those recorded in Table II. 
The study of the anti-protein antibodies is being continued and a more 
complete report will be made in a later communication. 
DISCUSSION 
Although the observations reported in this paper on a  relatively 
small number of patients represent an investigation which is, as yet, 
incomplete, sufficiently definite results have been obtained to  war- 
rant presentation.  It has been shown that pneumococcus polysac- 
charides, when injected intradermally into pneumonia patients after 
crisis, can bring about in some instances, a  local reaction.  The cu- 
taneous response, when obtained, was always elicited by the carbo- 
hydrate homologous to the type of pneumococcus causing infection in 
the patient.  A  patient's  capacity  to  react  became manifest  coin- 
cident with recovery from infection.  Furthermore, skin sensitivity 
has been found to parallel  closely the presence of  circulating type 
specific antibodies.  The two phenomena have been found to appear 
at about the same time, to persist for a similar period, and to disappear 
at about the Same stage of convalescence.  However, the mere pres- 
ence of type specific antibodies in the circulation is not the only fac- 
tor necessary for the excitation of a  skin response.  The fatal  case 
complicated by pneumococcus meningitis possessed type specific ag- 
glutinins in high titre but at no time could a definite,skin response be 
obtained.  Further investigation on a larger number of cases is neces- 
sary before the underlying mechanism can be fully interpreted.  How- 
ever, undetermined as the problem at the present may be, it is an 
interesting fact that these bacterial sugars, protein-free,  alad belonging 700  CUTANEOUS  REACTIONS  IN  LOBAR  PNEUMONIA 
to that group of immunologically specific substances known as hap- 
tens, are capable of producing a reaction in the skin of convalescents 
from pneumococcus pneumonia.  The character of the skin response 
incited by the polysaccharides is unique in that it is urticarial-like in 
appearance and runs its course in 1 to 2 hours. 
The reaction caused by pneumococcus  protein, on the other hand, is 
similar both in appearance and evolution to that evoked by tubercu- 
lin.  The  protein  reactions,  when  positive,  reached  the  maximum 
intensity about 24 hours after injection and some times required 3 to 
4 days to subside completely.  Furthermore, a patient's capacity to 
react to protein has no relation to the type of pneumococcus causing 
the infection.  Sufficient observations on the presence and quantita- 
tive variations of anti-protein antibodies have  not yet been made 
to justify final conclusions.  In the instances reported in this paper, 
antiprotein precipitins were found in all cases both before and after 
crisis.  In  any  single  individual  the  titre  did  not markedly vary 
during the course of disease, nor did it appear to influence skin sensi- 
tivity. 
The data presented in this paper represents observations made in 
the course of lobar pneumonia.  Similar tests on normal individuals 
and patients suffering from other diseases are being carried out and 
the results will be reported in a subsequent paper. 
CONCLUSIONS 
I.  a.  Pneumococcus polysaccharides, when injected intradermally 
into patients convalescent from pneumonia, are capable of eliciting a 
response.  The  polysaccharide  inducing  a  cutaneous  reaction  was 
found always to be homologous in type to that of the pneumococcus 
causing the infection. 
b.  The character of the reaction incited by the protein-free bacterial 
sugars is of the immediate wheal and erythema type. 
c.  A patient's capacity to react was found to be intimately asso- 
ciated both with recovery from infection and with the presence of 
type specific antibodies in the circulating blood. 
II.  a.  The  so-called  nucleo-protein  of  pneumococcus,  when  in- 
jected intradermally, also causes a local cutaneous reaction in patients 
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b.  The local lesion resulting from the injection of protein is tubercu- 
lin-like in character, and differs from that evoked by the type-specific 
polysaccharides  in  gross  appearance,  time  of  development,  and 
duration. 
c.  Individuals, acutely ill with and convalescent from pneumococcus 
pneumonia,  possess  in  their  circulating blood,  precipitins  reactive 
with pneumococcus protein.  In the observations recorded, the con- 
centration of anti-protein antibodies in the blood serum did not seem 
to influence the patient's capacity to react to intradermal injection of 
the protein. 
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EXPLANATION OF PLATE 32 
FIG. 1.  Cutaneous reaction 30 minutes after the injection of 0.01 mgm. of Type 
I polysaccharide  in a patient convalescent from Type I pneumococcus pneumonia. 
This illustrates the immediate wheal and erythema response  to pneumococcus 
polysaccharide,  Specific substances  of Types II and III, and salt solution are 
negative.  Roman numerals I, II, and III, designate the site of injection of Types 
I, II, and III carbohydrates; C represents the site of injection of salt solution. 
One-hale natural size. 
FIG. 2.  Cutaneous reaction 30 minutes after the injection of 0.01 mgm. of Type 
II polysaccharide in a patient convalescent from Type II pneumococcus  pneu- 
monia.  Specific substances of Types I  and I!I, and salt solution are negative. 
Roman numerals and C serve the same purpose as in Fig. 1.  One-half natural size. 
FIO. 3.  Cutaneous reaction 24 hours after injection produced by 0.01 mgm. of 
pneumococcus  protein.  This illustrates the delayed tuberculin-like response to 
pneumococcus protein.  Four-fifths naturalsize. THE  JOURNAL OF  EXPERIMENTAL MEDICINE VOL. 50  PLATE  32 
(T~llett  and Francis: Cutaneous reactions in lobar pneumonia) 